Bradley T Kerridge1, Roger Pickering2, Patricia Chou2, Tulshi D Saha2, Deborah S Hasin3. 1. Epidemiology and Biometry Branch, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5635 Fishers Lane, Room 3075, Rockville, MD 20852, United States; New York State Psychiatric Institute, 1051 Riverside Drive, Unite 123, New York, NY 10032, United States. Electronic address: bradley.kerridge@nih.gov. 2. Epidemiology and Biometry Branch, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5635 Fishers Lane, Room 3075, Rockville, MD 20852, United States. 3. Department of Psychiatry, College of Physicians and Surgeons, Mailman School of Public Health, Columbia University, New York State Psychiatric Institute, New York, NY 10032, United States.
Abstract
OBJECTIVE: The objective of this study was to present current information on the prevalence, correlates, comorbidity and quality of life among men and women with cannabis use disorder (CUD). METHODS: In 2012-2013, 36,309 respondents ≥18years old participated in face-to-face interviews in the National Epidemiologic Survey on Alcohol and Related Conditions-III. RESULTS: Prevalence of 12-month CUD was greater among men (3.5%) than women (1.7%). Women experienced shorter duration from onset of cannabis use to onset of CUD than men (mean=5.8years, men; mean=4.7years, women). In both men and women, prevalences of CUD were greater among young adults, Blacks, and those with lower income and greater among Native American women relative to White women. CUD was highly comorbid with other substance use disorders, PTSD, ASPD and borderline and schizotypal PDs for men and women. Quality of life for individuals with CUD was low regardless of gender. CONCLUSIONS: DSM-5 CUD among men and women is highly prevalent, comorbid and characterized by low quality of life. Results highlighted the need for integrated treatment of CUD and comorbid disorders and the urgency of identifying and implementing effective prevention and intervention approaches, especially for those sociodemographic subgroups for which both men and women are at greater risk for the disorder. Published by Elsevier Ltd.
OBJECTIVE: The objective of this study was to present current information on the prevalence, correlates, comorbidity and quality of life among men and women with cannabis use disorder (CUD). METHODS: In 2012-2013, 36,309 respondents ≥18years old participated in face-to-face interviews in the National Epidemiologic Survey on Alcohol and Related Conditions-III. RESULTS: Prevalence of 12-month CUD was greater among men (3.5%) than women (1.7%). Women experienced shorter duration from onset of cannabis use to onset of CUD than men (mean=5.8years, men; mean=4.7years, women). In both men and women, prevalences of CUD were greater among young adults, Blacks, and those with lower income and greater among Native American women relative to White women. CUD was highly comorbid with other substance use disorders, PTSD, ASPD and borderline and schizotypal PDs for men and women. Quality of life for individuals with CUD was low regardless of gender. CONCLUSIONS: DSM-5 CUD among men and women is highly prevalent, comorbid and characterized by low quality of life. Results highlighted the need for integrated treatment of CUD and comorbid disorders and the urgency of identifying and implementing effective prevention and intervention approaches, especially for those sociodemographic subgroups for which both men and women are at greater risk for the disorder. Published by Elsevier Ltd.
Entities:
Keywords:
Cannabis use disorder; Comorbidity; Quality of life; Sociodemographic correlates
Authors: Jason P Connor; Daniel Stjepanović; Bernard Le Foll; Eva Hoch; Alan J Budney; Wayne D Hall Journal: Nat Rev Dis Primers Date: 2021-02-25 Impact factor: 52.329
Authors: Maria A Parker; Joanna M Streck; Cecilia L Bergeria; Janice Y Bunn; Diann E Gaalema; Danielle R Davis; Anthony J Barrows; Stacey C Sigmon; Jennifer W Tidey; Sarah H Heil; Stephen T Higgins Journal: Tob Regul Sci Date: 2018-09
Authors: Gwen T Lapham; Cynthia I Campbell; Bobbi Jo H Yarborough; Rulin C Hechter; Brian K Ahmedani; Irina V Haller; Andrea H Kline-Simon; Derek D Satre; Amy M Loree; Constance Weisner; Ingrid A Binswanger Journal: Subst Abus Date: 2019-01-18 Impact factor: 3.716
Authors: Stephanie C Reed; Margaret Haney; Jeanne Manubay; Bianca R Campagna; Brian Reed; Richard W Foltin; Suzette M Evans Journal: Pharmacol Biochem Behav Date: 2018-12-04 Impact factor: 3.533
Authors: Shikha Prashad; Ryan P Hammonds; Amanda L Wiese; Amber L Milligan; Francesca M Filbey Journal: Drug Alcohol Depend Date: 2020-02-19 Impact factor: 4.492